| Th17 and natural Treg cell population dynamics in systemic lupus erythematosus J Yang, Y Chu, X Yang, D Gao, L Zhu, X Yang, L Wan, M Li Arthritis & Rheumatism 60 (5), 1472-1483, 2009 | 581 | 2009 |
| FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3–CCL2 signaling X Yang, Y Lin, Y Shi, B Li, W Liu, W Yin, Y Dang, Y Chu, J Fan, R He Cancer research 76 (14), 4124-4135, 2016 | 538 | 2016 |
| MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2 S Xiong, Y Zheng, P Jiang, R Liu, X Liu, Y Chu International journal of biological sciences 7 (6), 805, 2011 | 262 | 2011 |
| Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4+ CD25+ regulatory T cells X Ren, F Ye, Z Jiang, Y Chu, S Xiong, Y Wang Cell Death & Differentiation 14 (12), 2076-2084, 2007 | 255 | 2007 |
| Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy L Zhang, K Dermawan, M Jin, R Liu, H Zheng, L Xu, Y Zhang, Y Cai, ... Clinical immunology 129 (2), 219-229, 2008 | 245 | 2008 |
| SIRT5 desuccinylates and activates pyruvate kinase M2 to block macrophage IL-1β production and to prevent DSS-induced colitis in mice F Wang, K Wang, W Xu, S Zhao, D Ye, Y Wang, Y Xu, L Zhou, Y Chu, ... Cell reports 19 (11), 2331-2344, 2017 | 243 | 2017 |
| The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth Z Luo, G Yu, HW Lee, L Li, L Wang, D Yang, Y Pan, C Ding, J Qian, L Wu, ... Cancer research 72 (13), 3360-3371, 2012 | 242 | 2012 |
| The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy J Qian, C Wang, B Wang, J Yang, Y Wang, F Luo, J Xu, C Zhao, R Liu, ... Journal of neuroinflammation 15, 1-13, 2018 | 218 | 2018 |
| Differential expression of CXCR4 is associated with the metastatic potential of human non–small cell lung cancer cells L Su, J Zhang, H Xu, Y Wang, Y Chu, R Liu, S Xiong Clinical cancer research 11 (23), 8273-8280, 2005 | 216 | 2005 |
| SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1α–Dependent Glycolysis G Liu, Y Bi, B Shen, H Yang, Y Zhang, X Wang, H Liu, Y Lu, J Liao, ... Cancer research 74 (3), 727-737, 2014 | 184 | 2014 |
| Overactivated neddylation pathway as a therapeutic target in lung cancer L Li, M Wang, G Yu, P Chen, H Li, D Wei, J Zhu, L Xie, H Jia, J Shi, C Li, ... Journal of the National Cancer Institute 106 (6), dju083, 2014 | 183 | 2014 |
| TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells Y Zhang, F Luo, Y Cai, N Liu, L Wang, D Xu, Y Chu The Journal of Immunology 186 (4), 1963-1969, 2011 | 149 | 2011 |
| Lipid metabolism in inflammation-related diseases C Zhang, K Wang, L Yang, R Liu, Y Chu, X Qin, P Yang, H Yu Analyst 143 (19), 4526-4536, 2018 | 140 | 2018 |
| Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients—a single institution retrospective study of 292 lung adenocarcinoma J Gu, C Lu, J Guo, L Chen, Y Chu, Y Ji, D Ge Journal of surgical oncology 107 (5), 474-480, 2013 | 126 | 2013 |
| T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus X Yang, J Yang, Y Chu, Y Xue, D Xuan, S Zheng, H Zou PloS one 9 (2), e88441, 2014 | 125 | 2014 |
| DNMT1–MicroRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9–EGFR–AKT signaling R Liu, J Gu, P Jiang, Y Zheng, X Liu, X Jiang, E Huang, S Xiong, F Xu, ... Clinical Cancer Research 21 (4), 854-863, 2015 | 120 | 2015 |
| Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing LX Wang, R Li, G Yang, M Lim, A O'Hara, Y Chu, BA Fox, NP Restifo, ... Cancer research 65 (22), 10569-10577, 2005 | 120 | 2005 |
| Multifaceted modulation of SIRT1 in cancer and inflammation H Yang, Y Bi, L Xue, J Wang, Y Lu, Z Zhang, X Chen, Y Chu, R Yang, ... Critical Reviews™ in Oncogenesis 20 (1-2), 2015 | 119 | 2015 |
| The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase‐2 expression in clear cell renal cell carcinoma JF Li, YW Chu, GM Wang, TY Zhu, RM Rong, J Hou, M Xu BJU international 103 (3), 399-405, 2009 | 119 | 2009 |
| Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma G Roex, M Timmers, K Wouters, D Campillo-Davo, D Flumens, ... Journal of hematology & oncology 13, 1-14, 2020 | 118 | 2020 |
